Clinical Trial Update: The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS. [NA]

View source ↗

Summary

The NO-ALS study, sponsored by Haukeland University Hospital, is evaluating a nicotinamide/pterostilbene supplement for amyotrophic lateral sclerosis, and the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Nicotinamide (nicotinamide)
• Pterostilbene (pterostilbene)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Amyotrophic Lateral Sclerosis | NA | Status: ACTIVE_NOT_RECRUITING